Is DAA therapy for hepatitis C associated with an increased risk of liver cancer?

According to data from studies being presented at ILC™ 2017, there remains continued debate on whether patients are at risk of developing liver cancer after achieving SVR with a DAA regimen for HCV. Investigators will present study results that show both sides of the argument — DAA therapy is associated with higher risk of liver cancer compared with interferon-based therapy, versus there is no difference in liver cancer risk following cure with either therapy. …read more

Source: EurekAlert

(Visited 4 times, 1 visits today)

Popular Posts